Yili shares: invested 130 million yuan to set up Anhui Jianwei Seed Fund. Yili shares announced that the company's wholly-owned limited partnerships, Jianwei Capital, Jianwei Seed Fund, Jianwei Parent Fund and Anhui Seed Fund jointly invested to set up Anhui Jianwei Seed Fund, with a total subscribed capital of 200 million yuan, and the company's wholly-owned limited partnerships contributed a total of 130 million yuan. The partnership term of the partnership enterprise is 12 years, and the fund can be extended twice for 1 year at the expiration of the term. The investment direction is mainly for the top ten emerging industries in Anhui Province, the future industries in the layout of new industries in various cities in the province and other key industries developed by the municipal government, focusing on small and medium-sized scientific and technological innovative enterprises with certain scientific and technological content and relatively new business models. The CSRC approved the registration application of Jiangnan New Materials Technology Co., Ltd. for initial public offering of shares.
Twenty-five pilot banks in Shenzhen have opened a total of 64,000 cross-border wealth management accounts. The reporter was informed that by the end of November 2024, 25 pilot banks in Shenzhen had opened a total of 64,000 cross-border wealth management accounts, with a total amount of cross-border receipts and payments of 42.74 billion yuan, accounting for 48.1% and 44.2% of Guangdong-Hong Kong-Macao Greater Bay Area respectively.In the first three quarters, China's total cargo transportation was 41.63 billion tons, up 2.3% year-on-year. The China Federation of Logistics and Purchasing released the China Road Freight Development Report (2023-2024) today (13th). According to the report, due to the adjustment of transportation structure, although the proportion of road transportation in China has declined, it is still the main body of the freight market, and road freight has maintained steady growth. According to the report, in the first three quarters of this year, China's total cargo transportation was 41.63 billion tons, up 2.3% year-on-year. From the perspective of freight structure, the proportion of freight undertaken by railway and waterway transportation has increased, while the proportion of road transportation has decreased. In the first three quarters, the volume of road freight transport was 30.66 billion tons, up 3.1% year-on-year, accounting for more than 73%. Road transport is still the main body of the freight market. (CCTV News)The retail price of refined oil may end up stranded. According to calculation, as of the seventh working day on December 13th, the average price of reference crude oil varieties was 70.58 USD/barrel, with a change rate of -0.87%, and the corresponding domestic retail price of gasoline and diesel should be lowered by 40 yuan/ton. At 24: 00 on December 18th, it is the last price adjustment window of the retail price in 2024, so the retail price is likely to end stranded. By December 13th, 2024, the domestic retail price of gasoline and diesel had experienced "9 up, 9 down and 6 stranded". After the fluctuation offset, gasoline and diesel (standard products) were reduced by 115 yuan/ton and 125 yuan/ton respectively. (Jin Lianchuang)
Beijing Daxing Airport opened direct flights to Sydney and Melbourne for the first time. At 1: 10am on December 13th, China Southern Airlines flight CZ5025 took off from Beijing Daxing International Airport for Sydney, Australia, which was the first direct flight from Beijing Daxing Airport to Australia. On the 14th, China Southern Airlines will also fly the Daxing-Melbourne route in Beijing. (CCTV News)Market News: It is reported that Morgan Stanley will buy a mortgage loan from Santander Bank, worth about 900 million euros.Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14